Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

With These Hot Test Results, There's Now a Buyout Bull's-Eye on This Biotech

Shares of Private Briefing biotech Galapagos NV (OTC ADR: GLPYY) jumped 15.8% today on news that its rheumatoid arthritis (RA) drug presented "statistically significant" results in a Phase II study.

The Belgium biotech was the very first stock that we recommended on the very first day we published Private Briefing back in August 2011. The shares are up 256% since then.

Full Story

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK